Description
GLP-2 (T) Research Peptide
GLP-2 (T) Research Peptide is a synthetic modified peptide analog intended for controlled laboratory and analytical research. The designation identifies a specific modified peptide material rather than serving as a universal standardized name for all GLP-2-related compounds.
The product can be characterized through appropriate analytical techniques and evaluated in controlled experimental systems involving peptide structure, stability, molecular interactions, and receptor-binding research.
The indexed product information associated with this material describes a modified peptide containing linker/conjugation features designed for experimental investigations of peptide properties and receptor interactions.
For LV Longevity Peptides, the current batch-specific Certificate of Analysis should remain the authoritative source for chemical identity, molecular weight, purity, quantity, and other analytical specifications.
What Is GLP-2 (T) Research Peptide ?
GLP-2 (T) is a catalog-designated synthetic peptide research material.
The “T” designation should not automatically be interpreted as meaning that the product is simply native GLP-2 or a standardized pharmaceutical ingredient. Current industry references use the GLP-2-T designation inconsistently, making precise chemical documentation particularly important.
This distinction is valuable for researchers because different peptide materials can have substantially different sequences, modifications, molecular weights, and analytical characteristics.
Chemical Information
The supplied source currently lists the following reference characteristics for its GLP-2 (T) material:
| Specification | Reference Information |
|---|---|
| Product | GLP-2 (T) Research Peptide |
| Type | Modified synthetic peptide analog |
| Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular Weight | 4813.53 g/mol |
| Sequence | H-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-γ-Glu-[2×AEEA]-Lys-Lys-Lys-Thr-Lys-Thr-Cys-OH (This sequence reflects modifications and conjugation for prolonged half-life and experimental receptor binding studies.) |
Research Applications
Peptide Structural Research
GLP-2 (T) can be evaluated as a modified peptide construct in analytical studies examining molecular structure and peptide characteristics.
Stability Studies
Researchers may investigate the stability and degradation characteristics of the material under controlled experimental conditions.
Receptor-Binding Research
The modified peptide can be incorporated into appropriate experimental systems designed to investigate peptide-receptor interaction characteristics.
Analytical Characterization
Appropriate laboratory techniques can be used to evaluate peptide identity, molecular characteristics, purity, and composition.
Modified Peptide Research
The material can also support comparative studies involving peptide modifications, linker strategies, and structure-property relationships.
These applications are consistent with the research-oriented description associated with the supplied product information.
FAQ
What is GLP-2 (T)?
GLP-2 (T) is a catalog designation for a modified synthetic peptide analog supplied for controlled laboratory research.
Is GLP-2 (T) the same as native GLP-2?
Not necessarily. The “GLP-2 (T)” designation can refer to a modified research peptide rather than native GLP-2. The exact sequence and chemical identity should be verified against the applicable product COA.
What is GLP-2 (T) used for?
It is intended for non-clinical research involving peptide structure, analytical characterization, stability, molecular interactions, and receptor-binding studies.
What is the GLP-2 (T) molecular weight?
The supplied reference page lists 4,813.53 g/mol, but LV Longevity Peptides should use the molecular weight documented on its own batch-specific COA.
What is the GLP-2 (T) sequence?
The supplied reference information lists:
H-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-γ-Glu-[2×AEEA]-Lys-Lys-Lys-Thr-Lys-Thr-Cys-OH
Because modifications and commercial designations can vary, the LV product page should publish the sequence only after verification against the applicable COA.
